Codiak BioSciences logo
Codiak BioSciences CDAK
report update icon

Quarterly report 2022-Q3
added 11-21-2026

Codiak BioSciences Operating Expenses | CDAK

Annual Operating Expenses Codiak BioSciences

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
92.5 M 93.8 M 80.5 M 46.4 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
93.8 M 46.4 M 78.3 M

Quarterly Operating Expenses Codiak BioSciences

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 21.9 M 20.2 M 21 M 24.3 M 22.7 M 22.4 M 23.1 M 19.2 M 36 M 16 M 22.6 M - 21.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
36 M 16 M 22.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
Annexon Annexon
ANNX
216 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
11.1 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
24.7 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
787 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
754 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
4.49 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
8.51 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
16.5 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
41.1 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
38.7 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
48.2 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
77 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
61.1 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
1.23 B - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
187 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
22.4 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
32.7 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
285 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
197 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
98.7 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
9.73 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
42.6 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
86.8 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
330 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
14.8 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
177 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
18.7 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
12.1 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
13.9 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
46.3 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
37 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
106 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
163 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
265 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
22.7 M - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
61.3 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
64.6 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
56.6 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
50 M - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
156 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
80 M - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
61.5 M - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
340 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
24.6 M - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
13.5 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
84.4 M $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
137 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
269 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
19.4 M - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
153 M - - $ 58.1 M usaUSA